China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
CPHI stock price ended at $0.62 on 星期四, after dropping 3.13%
On the latest trading day Jun 25, 2026, the stock price of CPHI fell by 3.13%, dropping from $0.72 to $0.62. During the session, the stock saw a volatility of 16.13%, with prices oscillating between a daily low of $0.62 and a high of $0.72. On the latest trading day, the trading volume for CPHI decreased by 4.5K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 45.8K shares were traded, with a market value of approximately $25.1M.
Comment les indicateurs d'analyse technique s'appliquent-ils à CPHI ?
Selon l'analyse technique, China Pharma Holdings Inc a un signal agrégé de Sell. China Pharma Holdings Inc a 2 signaux d'achat, 1 signaux neutres et 4 signaux de vente.
Quels sont les niveaux de retracement de Fibonacci pour CPHI ?
Le niveau de retracement de Fibonacci de China Pharma Holdings Inc est 介於 0% 和 23.6% 之間。
Quel est le RSI de China Pharma Holdings Inc ?
Le RSI de China Pharma Holdings Inc est actuellement de 30.79, indiquant une condition 中立
Quel est le prix de China Pharma Holdings Inc pour les 12 prochains mois ?
Le prix de China Pharma Holdings Inc CPHI pour les 12 prochains mois est estimé à $0.
Jusqu'où China Pharma Holdings Inc est-il attendu?
Selon les analystes de Wall Street, China Pharma Holdings Inc devrait atteindre une prévision haute de $0.